Drug Patents owned by Ibsa Inst Bio

1. List of Licart drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11351133 IBSA INST BIO Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug
Feb, 2035

(11 years from now)

US11344520 IBSA INST BIO Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug
Feb, 2035

(11 years from now)

Do you want to check out LICART patents from before 2022?

Drugs and Companies using DICLOFENAC EPOLAMINE ingredient

Market Authorisation Date: 19 December, 2018

Treatment: Method of treating acute pain due to minor strains, sprains, and contusions using a diclofenac patch containing heparin for once daily administration where heparin is not released

Dosage: SYSTEM;TOPICAL

More Information on Dosage

LICART family patents

7

United States

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic